Cited by 538Antifungal resistance and susceptibilityFungal Infections and StudiesAntibiotics Pharmacokinetics and Efficacy

The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.

Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions

Open access

Stone, Neil R. H., Bicanic, Tihana, Salim, Rahuman, Hope, William·2016·Drugs

DOI 10.1007/s40265-016-0538-7PMC PMC4856207

Open this paper in CoChat — free account

Abstract

Liposomal amphotericin B (AmBisome(®); LAmB) is a unique lipid formulation of amphotericin B. LAmB is a standard of care for a wide range of medically important opportunistic fungal pathogens. LAmB has a significantly improved toxicity profile compared with conventional amphotericin B deoxycholate (DAmB). Despite nearly 20 years of clinical use, the pharmacokinetics and pharmacodynamics of this agent, which differ considerably from DAmB, remain relatively poorly understood and underutilized in the clinical setting. The molecular pharmacology, preclinical and clinical pharmacokinetics, and clinical experience with LAmB for the most commonly encountered fungal pathogens are reviewed. In vitro, experimental animal models and human clinical trial data are summarized, and novel routes of administration and dosing schedules are discussed. LAmB is a formulation that results in reduced toxicity as compared with DAmB while retaining the antifungal effect of the active agent. Its long terminal half-life and retention in tissues suggest that single or intermittent dosing regimens are feasible, and these should be actively investigated in both preclinical models and in clinical trials. Significant gaps remain in knowledge of pharmacokinetics and pharmacodynamics in special populations such as neonates and children, pregnant women and obese patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s40265-016-0538-7

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Bone marrow transplant
Szer, J. (1999) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb127745.x · Cited by 3,373
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,705
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Phase transitions in phospholipid vesicles Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol
Papahadjopoulos, D., Jacobson, K., Nir, S., & Isac, I. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90314-3 · Cited by 998
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever
Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979
Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszyńska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 907
Amphotericin B formulations: a comparative review of efficacy and toxicity
Hamill, R. J. (2013) · Drugs · doi:10.1007/s40265-013-0069-4 · Cited by 807
Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)
Cornely, O. A., Maertens, J. A., Bresnik, M., Ebrahimi, R., Ullmann, A. J., Bouza, E., Heußel, C. P., Lortholary, O., Rieger, C. T., Boehme, A., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/514341 · Cited by 744

Show all 119 references

Research works printed but not linked: 1

Joint Formulary Committee. British National Formulary. 70th ed. London: BMJ Group and Pharmaceutical Press;2015.

Sorted by citations

Items 201–300 of 538

Sensitive LC-MS/MS Methods for Amphotericin B Analysis in Cerebrospinal Fluid, Plasma, Plasma Ultrafiltrate, and Urine: Application to Clinical Pharmacokinetics
Pippa, L. F., Marques, M. P., da Silva, A. C. T., Vilar, F. C., de Haes, T. M., da Fonseca, B. A. L., Martínez, R., Coelho, E. B., Wichert‐Ana, L., & Lanchote, V. L. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.782131 · Cited by 16
Updates in the Pharmacologic Prophylaxis and Treatment of Invasive Candidiasis in the Pediatric and Neonatal Intensive Care Units
Fly, J. H., Kapoor, S., Bobo, K. S., & Stultz, J. S. (2022) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-022-00258-z · Cited by 16
Bronchoscopic instillation of amphotericin B is a safe and effective measure to treat pulmonary mycosis
Yang, L., Yang, C.-Q., Wan, N., Xie, W., Tian, Y., Xiao, Y., Luo, L., Chen, E., Zhang, J., Wang, X., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1167475 · Cited by 16
Autoantigen‐Dexamethasone Conjugate‐Loaded Liposomes Halt Arthritis Development in Mice
Benne, N., ter Braake, D., Porenta, D., Lau, C. Y. J., Mastrobattista, E., & Broere, F. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304238 · Cited by 16
Natural product‐based nanomedicine applied to fungal infection treatment: A review of the last 4 years
Marena, G. D., Ramos, M. A. D. S., Carvalho, G. C., Paris, J. A., Resende, F. A., Corrêa, I., Ono, G. Y. B., Araújo, V. H. S., de Camargo, B. A. F., Bauab, T. M., et al. (2022) · Phytotherapy Research · doi:10.1002/ptr.7460 · Cited by 17
CD44 receptor targeted nanoparticles augment immunity against tuberculosis in mice
Singh, V. K., Chau, E. P., Mishra, A., DeAnda, A., Hegde, V. L., Sastry, K. J., Haviland, D., Jagannath, C., Godin, B., & Khan, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.07.040 · Cited by 16
Synthesis and evaluation of styrene-maleic acid copolymer conjugated amphotericin B
Banshoya, K., Kaneo, Y., Tanaka, T., Yamamoto, S., & Maeda, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118719 · Cited by 16
Development of a novel anti-biofilm peptide derived from profilin of Spodoptera frugiperda
da Silva, A. C. B., Sardi, J. D. C. O., de Oliveira, D. G. L., de Oliveira, C. F. R., dos Santos, H. F., dos Santos, E. L., Crusca, E., Cardoso, M. H. E. S., Franco, O. L., & Macedo, M. L. R. (2020) · Biofouling · doi:10.1080/08927014.2020.1776857 · Cited by 15
AmBisome® Formulations for Pediatrics: Stability, Cytotoxicity, and Cost-Effectiveness Studies
Zuccari, G., Villa, C., Iurilli, V., Barabino, P., Zorzoli, A., Marimpietri, D., Caviglia, D., & Russo, E. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040466 · Cited by 15
Nanocarriers' repartitioning of drugs between blood subcompartments as a mechanism of improving pharmacokinetics, safety, and efficacy
Zaleski, M. H., Omo‐Lamai, S., Nong, J., Chase, L. S., Myerson, J. W., Glassman, P. M., Lee, F. T., Reyes‐Esteves, S., Wang, Z., Patel, M. N., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.070 · Cited by 18
Antifungal treatment administered in OPAT programs is a safe and effective option in selected patients
Gil-Navarro, M. V., Márquez, R. L., Gutiérrez, N. B., Álvarez‐Marín, R., Navarro-Amuedo, M. D., Praena‐Segovia, J., Carmona-Caballero, J. M., Fraile-Ramos, E., & López-Cortés, L. E. (2020) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2020.01.019 · Cited by 15
Low-dose liposomal amphotericin B for antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell transplantation
Mendoza‐Palomar, N., Vallejo, E. S., Benítez‐Carabante, M. I., González-Amores, M., Fernández-Polo, A., Renedo, B., Martín-Gómez, M. T., Soler‐Palacín, P., & de Heredia, C. D. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa149 · Cited by 15
When Azoles Cannot Be Used: The Clinical Effectiveness of Intermittent Liposomal Amphotericin Prophylaxis in Hematology Patients
Batchelor, R., Thomas, C., Gardiner, B. J., Lee, S., Fleming, S. A., Wei, A. H., Coutsouvelis, J., & Ananda-Rajah, M. R. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab113 · Cited by 15
Efficacy of Combined Rifampicin Formulations Delivered by the Pulmonary Route to Treat Tuberculosis in the Guinea Pig Model
Garcia‐Contreras, L., Sethuraman, V. V., Kazantseva, M., & Hickey, A. J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081309 · Cited by 15
Nanotherapeutics approaches for targeting alpha synuclien protein in the management of Parkinson disease
Singh, A., Maharana, S. K., Shukla, R., & Kesharwani, P. (2021) · Process Biochemistry · doi:10.1016/j.procbio.2021.08.008 · Cited by 16
Association between fluid infusions and the recovery from acute kidney injury in patients administered liposomal amphotericin B: a nationwide observational study
Tashiro, M., Obata, Y., Takazono, T., Ota, Y., Wakamura, T., Shiozawa, Y., Tsuyuki, A., Miyazaki, T., Nishino, T., & Izumikawa, K. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2036618 · Cited by 15
Analysis of the Interactions of Amphotericin B with the Leishmania Plasma Membrane Using EPR Spectroscopy
Alonso, L., Mendanha, S. A., Dorta, M. L., & Alonso, A. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c07721 · Cited by 15
Lipid conjugate dissociation analysis improves the in vivo understanding of lipid-based nanomedicine
van Os, W. L., Wielaert, L., Alter, C. L., Davidović, D., Šachl, R., Kock, T. J. F., González, U. U., Arias‐Alpizar, G., Vigario, F. L., Knol, R. A., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.034 · Cited by 14
Future perspectives for cryptococcosis treatment
Santos-Gandelman, J. F., Rodrigues, M. L., & Silva, A. M. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1503252 · Cited by 15
Superenhanced Removal of Fungal Biofilms by Protease‐Functionalized Amphotericin B Nanocarriers
Weldrick, P. J., Hardman, M. J., & Paunov, V. N. (2020) · Advanced NanoBiomed Research · doi:10.1002/anbr.202000027 · Cited by 15
Exposure of Aspergillus fumigatus to Atorvastatin Leads to Altered Membrane Permeability and Induction of an Oxidative Stress Response
Ajdidi, A., Sheehan, G., & Kavanagh, K. A. (2020) · Journal of Fungi · doi:10.3390/jof6020042 · Cited by 12
In Vitro Evaluation of Radiolabeled Amphotericin B for Molecular Imaging of Mold Infections
Page, L., Ullmann, A. J., Schadt, F., Wurster, S., & Samnick, S. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02377-19 · Cited by 14
Intravenous therapy for chronic pulmonary aspergillosis: A systematic review and meta‐analysis
Bongomin, F., Asio, L. G., Olum, R., & Denning, D. W. (2020) · Mycoses · doi:10.1111/myc.13131 · Cited by 14
Transmembrane Ion Channels: From Natural to Artificial Systems
Yan, T., & Liu, J. (2024) · Angewandte Chemie · doi:10.1002/ange.202416200 · Cited by 13
Translational Insights into Liposomal Drug Delivery: Recent Advances, Therapeutic Applications, and Clinical Trials
Shadab, A., & Ansari, A. F. (2026) · Drug Research · doi:10.1055/a-2795-7008 · Cited by 13
Epidemiology, Clinical Characteristics, Diagnostic Work Up, and Treatment Options of Leishmania Infection in Kidney Transplant Recipients: A Systematic Review
Favi, E., Santolamazza, G., Botticelli, F. M. G., Alfieri, C., Delbue, S., Cacciola, R., Guarneri, A., & Ferraresso, M. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7100258 · Cited by 13
Liposomes as Drug Carriers: Classification, Preparation Methods, and Medicinal Use
Бурдаев, Н. И., Николаева, Л. Л., Kosenko, V. V., Шпрах, З. С., & Bunyatyan, N. D. (2023) · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · doi:10.30895/1991-2919-2023-508 · Cited by 17
In silico and in vitro potentials of crocin and amphotericin B on Leishmania major: Multiple synergistic mechanisms of actions
Salarkia, E., Sharifi, I., Keyhani, A., Oliaee, R. T., Khosravi, A., Sharifi, F., Bamorovat, M., & Babaei, Z. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291322 · Cited by 13
Commercial Methods for Antifungal Susceptibility Testing of Saprophytic Molds: Can They Be Used to Detect Resistance?
Paranos, P., Espinel‐Ingroff, A., & Meletiadis, J. (2024) · Journal of Fungi · doi:10.3390/jof10030214 · Cited by 14
Traditional Chinese medicine-based drug delivery systems for anti-tumor therapies
Ling, Y. A. N. G., Wang, Y., Ye, X., Liu, Q., Qu, D., & Chen, Y. (2024) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(24)60746-6 · Cited by 13
Recent plant-based nanomedicine and nanocarrier for cancer treatment
Shukla, M. K., Das, A. K., Gaurav, A., Bisht, D., Singh, A., & Kumar, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95325-2.00011-0 · Cited by 13
Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B
van de Peppel, R. J., Schauwvlieghe, A. F. A. D., Daele, R. V., Spriet, I., Wout, J. W. V., Brüggemann, R. J. M., Rijnders, B. J. A., Hendriks, B. J. C., & de Boer, M. G. J. (2019) · Medical Mycology · doi:10.1093/mmy/myz134 · Cited by 13
Radiolabeled Tedizolid Phosphate Liposomes for Topical Application: Design, Characterization, and Evaluation of Cellular Binding Capacity
Karpuz, M., Gündoğdu, E., Demir, E. S., & Şenyiğit, Z. A. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-020-01917-4 · Cited by 13
Hijacking the intrinsic vitamin B 12 pathway for the oral delivery of nanoparticles, resulting in enhanced in vivo anti-leishmanial activity
Singh, A., Yadagiri, G., Javaid, A., Sharma, K. K., Verma, A. K., Singh, O. P., Sundar, S., & Mudavath, S. L. (2022) · Biomaterials Science · doi:10.1039/d2bm00979j · Cited by 14
Cutting-edge advances in transethosomes and nanoethosomes for transdermal drug delivery
Patra, P. (2025) · Discover Chemistry. · doi:10.1007/s44371-025-00232-w · Cited by 12
Smart Vesicle Therapeutics: Engineering Precision at the Nanoscale
Benedini, L. A., & Messina, P. V. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17121588 · Cited by 12
Stimuli-responsive nanocarriers for precision targeted and controlled antimicrobial drug delivery in drug-resistant infections
Dai, L., & Sun, X. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1803769 · Cited by 15
Clinical research advances of isavuconazole in the treatment of invasive fungal diseases
Zhang, T., Shen, Y., & Feng, S. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1049959 · Cited by 12
Nanogel Particles Based on Modified Nucleosides and Oligosaccharides as Advanced Delivery System
Itzhakov, R., Hak, H., Sadhasivam, S., Belausov, E., Fallik, E., Spiegelman, Z., Sionov, E., & Poverenov, E. (2023) · ACS Nano · doi:10.1021/acsnano.3c08627 · Cited by 12
Three-dimensional printing of medical devices and biomaterials with antimicrobial activity: A systematic review
Mace, M. A. M., Reginatto, C. L., Soares, R. M. D., & Fuentefría, A. M. (2024) · Bioprinting · doi:10.1016/j.bprint.2024.e00334 · Cited by 13
“Click” amphotericin B in prodrug nanoformulations for enhanced systemic fungemia treatment
Guo, D., Shi, C., Suo, L., Ji, X., Yue, H., Yuan, D., & Luo, J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.003 · Cited by 13
Candida auris Resistance Mechanisms to Amphotericin B Alternative Treatments Development
Fenton, A., & John, G. K. (2024) · Current Clinical Microbiology Reports · doi:10.1007/s40588-024-00233-w · Cited by 12
Photodynamic drug delivery for cancer therapy: Designing liposomes for light-controlled release and enhanced drug efficacy
Clainche, T. L., Abdelhamid, A. G. A., Gutierrez, N. M. C., Jourdain, M.-A., Leo, S., Sancey, L., Hurbin, A., Coll, J., Elena‐Herrmann, B., & Broekgaarden, M. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107221 · Cited by 12
Gender differences in acute toxicity, toxicokinetic and tissue distribution of amphotericin B liposomes in rats
Wang, D., Zhang, W., Ju, J.-X., Wang, L.-J., Huang, R., Xu, Y., Zhang, H., & Qi, J. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.12.004 · Cited by 12
Preventing preterm birth: New approaches to labour therapeutics using Nanoparticles
Paúl, J., & Smith, R. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.03.005 · Cited by 12
Chitosan-Based Oral Drug Delivery System for Peptide, Protein and Vaccine Delivery
Zainuddin, S. Z., & Hamid, K. A. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95771 · Cited by 12
Targeting Trypanothione Synthetase and Trypanothione Reductase: Development of Common Inhibitors to Tackle Trypanosomatid Disease
Augusto, A., Costa, I. C. C., Conceição, J., & Cristiano, M. L. S. (2025) · Pharmaceuticals · doi:10.3390/ph18081182 · Cited by 11
Pharmacological Management of Oral and Esophageal Candidiasis: A Clinical Pharmacotherapy Perspective
Hirai, T., & Nashi, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14217537 · Cited by 14
The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study
Obata, Y., Takazono, T., Tashiro, M., Ota, Y., Wakamura, T., Takahashi, A., Sato, K., Miyazaki, T., Nishino, T., & Izumikawa, K. (2020) · Clinical and Experimental Nephrology · doi:10.1007/s10157-020-01989-3 · Cited by 11
Histoplasmosis around the world: A global perspective on the presentation, virulence factors, and treatment of histoplasmosis
Gandhi, P., Hebert, B., Yun, A., Bradley, J. A., & Moldoveanu, B. (2024) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2024.06.011 · Cited by 12
Mechanism of action and synergistic effect of Eugenia uniflora extract in Candida spp.
de Souza, L. B. F. C., Bento, A. D. O., Lourenço, E. M. G., Ferreira, M. R. A., de Oliveira, W. N., Soares, L. A. L., Barbosa, E. G., Rocha, H. A. O., & Chaves, G. M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303878 · Cited by 12
Recent nanoengineered therapeutic advancements in sepsis management
Liu, L., Li, L., Wang, T., Li, Z., Yan, B., Tan, R., Zeng, A., Ma, W., Zhu, X. H., Yin, Z., et al. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1495277 · Cited by 11
British Thoracic Society Clinical Statement on Aspergillus -related chronic lung disease
Brown, J., Armstrong-James, D. P. H., Ayling-Smith, J., Backx, M., Coleman, M., Connell, D. W., Dennison, P., Downey, D. G., Lynch, F., Lim, W. S., et al. (2025) · Thorax · doi:10.1136/thorax-2024-222567 · Cited by 12
Nanomedicines and Nanodrug Delivery Systems: Trends and Perspectives
Das, S., Das, M. K., Deka, T., Singha, L. R., & Das, P. (2020) · Springer eBooks · doi:10.1007/978-981-15-6255-6_6 · Cited by 11
Targeted nanoparticles in pregnancy: a new frontier in perinatal therapeutics
Refuerzo, J., Longo, M., & Godin, B. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.01.025 · Cited by 11
Nanostructure self-assembly for direct nose-to-brain drug delivery
Chaud, M. V., Rios, A. C., dos Santos, C. A., de Barros, C. T., de Souza, J. F., & Alves, T. F. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817998-7.00019-7 · Cited by 11
Minimum concentration of Amphotericin B in serum according to the formulation, dose, and daily or prolonged intermittent therapeutic regimen
Schiave, L. A., Nascimento, É., Gaspar, G. G., Vilar, F. C., Martínez, E. Z., de Gaitani, C. M., & Martínez, R. (2020) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0463-2018 · Cited by 11
A Sojourn on Liposomal Delivery System: Recent Advances and Future Prospects
Kaur, S., & Singh, D. (2023) · Assay and Drug Development Technologies · doi:10.1089/adt.2022.089 · Cited by 11
Simultaneous determination of amphotericin B, tobramycin and vancomycin in rabbit ocular biofluids and tissues by LC-MS/MS: An antimicrobial therapy for keratitis and its PK-PD application
Mishra, A., Biswas, A., Choudhury, A. D., Verma, S., Prasad, Y. D., Singh, V., Bisen, A. C., Kumar, M., & Bhatta, R. S. (2023) · Journal of Chromatography B · doi:10.1016/j.jchromb.2023.123960 · Cited by 10
Enhanced Control of Liposomal Drug Release by Drug–Aptamer Complexes
Huang, X., Li, Y., Torre, M., Shao, R., Zhang, W., Wang, Z., Kohane, D. S., & Weldon, C. B. (2025) · Advanced Materials · doi:10.1002/adma.202503872 · Cited by 10
Assessing the Safety, Tolerability, Pharmacokinetics, and Biodistribution of Novel Oral Formulations of Amphotericin B following Single- and Multiple-Dose Administration to Beagle Dogs
Wasan, K. M., Wasan, E. K., & Hnik, P. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01111-20 · Cited by 10
Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-a]pyridine Antileishmanial Pharmacophore
Paoli-Lombardo, R., Primas, N., Bourgeade‐Delmas, S., Hutter, S., Sournia‐Saquet, A., Boudot, C., Brenot, E., Castera‐Ducros, C., Corvaisier, S., Since, M., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15080998 · Cited by 10
Novel pH-sensitive nanoparticles based on prodrug strategy to delivery All-Trans Retinoic Acid for breast cancer
Li, W., Gong, H., Fu, Y., Sun, J., & Wang, Y. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112838 · Cited by 10
Single Particle Chemical Characterisation of Nanoformulations for Cargo Delivery
Saunders, C., de Villiers, C. A., & Stevens, M. M. (2023) · The AAPS Journal · doi:10.1208/s12248-023-00855-w · Cited by 12
Nanotherapeutics as promising approaches to combat fungal infections
Kamel, R. (2019) · Drug Development Research · doi:10.1002/ddr.21533 · Cited by 10
In Vitro and In Vivo Exposure-Effect Relationship of Liposomal Amphotericin B against Aspergillus fumigatus
Siopi, M., Mouton, J. W., Pournaras, S., & Meletiadis, J. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02673-18 · Cited by 10
Enhanced Efficacy of Thiosemicarbazone Derivative-Encapsulated Fibrin Liposomes against Candidiasis in Murine Model
Khan, A. A., Alanazi, A. M., Alsaif, N. A., Algrain, N., Wani, T. A., & Bhat, M. A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030333 · Cited by 11
COVID-19 and Mucormycosis Coinfection: How Challenging It Is
Nayak, N., Khan, E. I., & Panigrahi, D. (2022) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2022/8617212 · Cited by 10
Engineering Telodendrimer Nanocarriers for Monomeric Amphotericin B Delivery
Ji, X., Shi, C., Guo, D., Yang, X., Suo, L., & Luo, J. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c01087 · Cited by 10
Drugs and nanoformulations for the management of Leishmania infection: a patent and literature review (2015-2022)
Verdan, M., Taveira, I. N., Lima, F., Abreu, F. D. Á., & Nico, D. (2023) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2023.2201431 · Cited by 10
Amphotericin B liposomal formulation: applicable preparation methods, challenges, and tips
Seify, R., Zahednezhad, F., Zakeri‐Milani, P., & Valizadeh, H. (2023) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2023.2215006 · Cited by 10
Successful stepdown treatment of pulmonary histoplasmosis with thrice‐weekly liposomal amphotericin B in a hospital‐associated, outpatient infusion centre: A case report
Lewis, P. O., Khan, I., & Patel, P. D. (2017) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12609 · Cited by 10
Pharmacology of Liposomal Amphotericin B: An Introduction to Preclinical and Clinical Advances for Treatment of Life-threatening Invasive Fungal Infections
Walsh, T. J., Lewis, R. E., & Adler‐Moore, J. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz091 · Cited by 10
Commensal colonization of Candida albicans in the mouse gastrointestinal tract is mediated via expression of candidalysin and adhesins
Mauk, K. E., Miramón, P., Lorenz, M. C., Lortal, L., Naglik, J. R., Hube, B., Bimler, L. H., Kheradmand, F., & Corry, D. B. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00567-25 · Cited by 10
Recent Advances in Nanoparticle Formulations for Treating Fungal Diseases
LaMastro, V., & Shukla, A. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202510532 · Cited by 10
Analysis of Hypokalemia as a Side Effect of Liposomal Amphotericin in Pediatric Patients
Kobayashi, R., Keino, D., Hori, D., Sano, H., Suzuki, D., Kishimoto, K., & Kobayashi, K. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001802 · Cited by 9
Association between potassium supplementation and the occurrence of acute kidney injury in patients with hypokalemia administered liposomal amphotericin B: a nationwide observational study
Ota, Y., Obata, Y., Takazono, T., Tashiro, M., Wakamura, T., Takahashi, A., Shiozawa, Y., Miyazaki, T., Nishino, T., & Izumikawa, K. (2021) · BMC Nephrology · doi:10.1186/s12882-021-02450-7 · Cited by 9
Liposomal formulation
Fu, Y., Saraswat, A. L., Vartak, R., Patki, M., & Patel, K. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85041-4.00021-4 · Cited by 9
Membrane-camouflaged biomimetic nanoparticles as potential immunomodulatory solutions for sepsis: An overview
Wang, Y., Liu, L., Zheng, X., & Liu, X. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1111963 · Cited by 8
Utilizing liposomal encapsulation approach to address nephrotoxic challenges of colistimethate sodium through a preclinical study
Mektrirat, R., Paengjun, N., Chongrattanameteekul, P., Umsumarng, S., Cheunsri, S., Photichai, K., Lewchalermvong, K., Sansamur, C., Okonogi, S., & Katip, W. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1282464 · Cited by 8
Cyclodextrin-Based Formulations as a Promising Strategy to Overcome the Blood–Brain Barrier: Historical Overview and Prospects in Glioblastoma Treatment
Gaetano, F. D., Totaro, N., & Ventura, C. A. (2025) · Pharmaceuticals · doi:10.3390/ph18111626 · Cited by 11
Liposomes as versatile drug delivery vehicles: emerging trends, technological innovations and future perspectives
Michael, A., Bhattacharya, D., Gopal, V., Suresh, D., Arun, J., & Ganesh, G. N. K. (2026) · Journal of Liposome Research · doi:10.1080/08982104.2026.2619919 · Cited by 8
Combination Therapy for HIV-Associated Cryptococcal Meningitis—A Success Story
Hurt, W. J., Harrison, T. S., Molloy, S. F., & Bicanic, T. A. (2021) · Journal of Fungi · doi:10.3390/jof7121098 · Cited by 8
Self-citation
Comparison of liposomal amphotericin B alone and in combination with flucytosine in the treatment of non‐HIV Cryptococcal meningitis: A nationwide observational study
Takazono, T., Hidaka, Y., Morimoto, S., Tashiro, M., Ashizawa, N., Hirayama, T., Takeda, K., Iwanaga, N., Hosogaya, N., Yamamoto, K., et al. (2022) · Mycoses · doi:10.1111/myc.13493 · Cited by 8
Efficacy Evaluation of 10-Hydroxy Chondrofoline and Tafenoquine against Leishmania tropica (HTD7)
Shah, S. I., Nasir, F., Malik, N. S., Alamzeb, M., Abbas, M., Rehman, I. U., Khuda, F., Shah, Y., Goh, K. W., Zeb, A., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15081005 · Cited by 8
Successful treatment of invasive tracheobronchial pulmonary aspergillosis with venovenous extracorporeal membrane oxygenation and combined systemic, intratracheal instillation of liposomal amphotericin B: a case report
Sato, S., Kamata, W., Fukaguchi, K., Tsunoda, S., Kamio, T., Koyama, H., Sugimoto, H., & Tamai, Y. (2022) · Journal of Medical Case Reports · doi:10.1186/s13256-022-03692-1 · Cited by 8
Antileishmanial activities of three chalcone derivatives and their association with plasma membrane rigidity as assessed by EPR spectroscopy
Borges, E. N., Alonso, L., Silveira, M. B., Balbinot, R. B., Nakamura, C. V., da Rocha, A. L. B., Arruda, E. L., Franco-dos-Santos, G., Vaz, B. G., Gomides, C. D., et al. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.136123 · Cited by 8
Delivery of cisplatin by folic acid-targeted liposomal nanoparticles into liver cancer cell line
Foroud, N., Ardjmand, M., Heydarinasab, A., & Akbarzadeh, A. (2017) · International Journal of Polymeric Materials · doi:10.1080/00914037.2017.1393676 · Cited by 8
Efficacy and Safety of Low-Dose Liposomal Amphotericin B in Adult Patients Undergoing Unrelated Cord Blood Transplantation
Yasu, T., Konuma, T., Oiwa‐Monna, M., Kato, S., Tanoue, S., Isobe, M., Mizusawa, M., Kuroda, S., Takahashi, S., & Tojo, A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01205-18 · Cited by 8
Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis
Voak, A. A., Harris, A., Coterón, J. M., Angulo‐Barturen, Í., Ferrer, S. B., Croft, S. L., & Seifert, K. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009013 · Cited by 8
Novel Nanocarrier Platform for Effective Treatment of Visceral Leishmaniasis
Kannan, S., Harel, Y., Israel, L. L., Lellouche, E., Varvak, A., Tsubery, M. N., Lellouche, J., & Michaeli, S. (2021) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.1c00381 · Cited by 8
A rapid and robust UHPLC-DAD method for the quantification of amphotericin B in human plasma
Barco, S., Zunino, A., D’Avolio, A., Barbagallo, L., Maffia, A., Tripodi, G., Castagnola, E., & Cangemi, G. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.01.048 · Cited by 11
Therapeutic Approaches for Combating Aspergillus Associated Infection
Chhillar, A. K., Punia, A., Choudhary, P., Sharma, N., Dahiya, S., & Gulia, P. (2022) · Current Drug Targets · doi:10.2174/1389450123666220623164548 · Cited by 8
Enhancing Gentamicin Antibacterial Activity by Co-Encapsulation with Thymoquinone in Liposomal Formulation
Alzahrani, R. R., Alkhulaifi, M. M., Al-Jeraisy, M., Albekairy, A. M., Ali, R., Alrfaei, B. M., Ehaideb, S. N., Al-Asmari, A. I., Qahtani, S. A., Halwani, A. M., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16101330 · Cited by 7
Improving antifungal lipid-based drug delivery against Candida : a review
Marena, G. D., Gaitán, A. C. R., Bauab, T. M., & Chorilli, M. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2421402 · Cited by 8
Vitamins as excipients in pharmaceutical products
Bayne, A.-C. V., Pessi, J., Bird, J. K., Stemmler, R. T., Frerichs, M., & Besheer, A. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107020 · Cited by 7
Insights on nanomaterials-fungi interactions: probing engineering principles for developing antifungal nanomedicines
Rocha, V., Carvalho, D., & das Neves, J. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125978 · Cited by 7
Impact of Biofilm Formation by Vaginal Candida albicans and Candida glabrata Isolates and Their Antifungal Resistance: A Comprehensive Study in Ecuadorian Women
Cedeño-Pinargote, A. C., Jara-Medina, N. R., Pineda-Cabrera, C. C., Cueva, D. F., Erazo-Garcia, M. P., Tejera, E., & Machado, A. (2025) · Journal of Fungi · doi:10.3390/jof11090620 · Cited by 10
The Fomivirsen, Patisiran, and Givosiran Odyssey: How the Success Stories May Pave the Way for Future Clinical Translation of Nucleic Acid Drugs
Mansouri, M., Mansouri, K., Taheri, Z., Alhashemi, S. H., & Dehshahri, A. (2025) · BioDrugs · doi:10.1007/s40259-025-00711-7 · Cited by 10
Topoisomerase IB poisons induce histone H2A phosphorylation as a response to DNA damage in Leishmania infantum
Gutiérrez-Corbo, C., Álvarez‐Velilla, R., Reguera, R. M., García‐Estrada, C., Cushman, M., Balaña‐Fouce, R., & Pérez‐Pertejo, Y. (2019) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2019.09.005 · Cited by 7

Authors: Stone, N. R. H., Bicanic, T., Salim, R., & Hope, W.
Affiliations: St George's, University of London (GB)
Royal Liverpool University Hospital (GB)
University of Liverpool (GB)
Corresponding author: Stone, Neil R. H.
ORCID: Stone, Neil R. H.
Bicanic, Tihana
Hope, William
Venue: Drugs
Publisher: Springer Science and Business Media LLC
Published: 2016-01-27
Volume: 76
Issue: 4
Pages: 485-500
ISSN: 0012-6667 (ISSN-L)
1179-1950
DOI: 10.1007/s40265-016-0538-7
PMC: PMC4856207
OpenAlex: W2298912458
Cited by: 537
References: 119
Citations by year: 2026: 52 · 2025: 81 · 2024: 73 · 2023: 61 · 2022: 73 · 2021: 60 · 2020: 55 · 2019: 40 · 2018: 16 · 2017: 23 · 2016: 1
FWCI: 4.10
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Drugs (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Wellcome Trust Strategic Award (Medical Mycology and Fungal Immunology) (RG12848-10)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Keywords: liposomal amphotericin B, amphotericin B deoxycholate, pharmacokinetics, pharmacodynamics, antifungal agents, opportunistic fungal infection, drug toxicity, dosing regimen, intermittent dosing, neonates, pregnancy, obesity, molecular pharmacology
MeSH terms: Amphotericin B, Animals, Chemistry, Pharmaceutical, Clinical Trials as Topic, Deoxycholic Acid, Drug Combinations, Half-Life, Humans, Tissue Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks